These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6029138)

  • 1. Cervical screening for carcinoma: a comparison of cytological and enzyme (6-phosphogluconate dehydrogenase) methods and clinical findings.
    Boyd JT; Gibbs DF; Labrum AH; Philps FR
    Br Med J; 1967 Jun; 2(5555):785-92. PubMed ID: 6029138
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for cervical cancer.
    Br Med J; 1967 Jun; 2(5555):782-3. PubMed ID: 6029136
    [No Abstract]   [Full Text] [Related]  

  • 3. Technical modifications of the 6-phosphogluconate dehydrogenase test of the vaginal fluid.
    Sanner T; Bergsjo P; Koller O; Kolstad P; Pihl A
    Am J Obstet Gynecol; 1967 Jul; 98(6):800-3. PubMed ID: 6027708
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of preinvasive and early invasive cancer by 6-phosphogluconate dehydrogenase determinations.
    Kolstad P; Bergsjo P; Koller O; Pihl A; Sanner T
    Am J Obstet Gynecol; 1967 Jul; 98(6):804-7. PubMed ID: 6027709
    [No Abstract]   [Full Text] [Related]  

  • 5. The early diagnosis of carcinoma of the female genital tract. I. 6-phosphogluconate dehydrogenase activity and carcinoma of the female genital tract.
    Moukhtar M; Higgins G
    J Obstet Gynaecol Br Commonw; 1965 Oct; 72(5):677-83. PubMed ID: 4284722
    [No Abstract]   [Full Text] [Related]  

  • 6. The early diagnosis of carcinoma of the female genital tract. II. Vaginal fluid 6-phosphogluconate dehydrogenase activity as a test for carcinoma of the cervix.
    Moukter M; Higgins G
    J Obstet Gynaecol Br Commonw; 1965 Oct; 72(5):684-90. PubMed ID: 5891592
    [No Abstract]   [Full Text] [Related]  

  • 7. The source of 6-phosphogluconate dehydrogenase in vaginal fluid samples.
    Churchouse MJ; Carter GN; Bonham DG
    J Obstet Gynaecol Br Commonw; 1967 Oct; 74(5):712-22. PubMed ID: 6058534
    [No Abstract]   [Full Text] [Related]  

  • 8. 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID: LIMITATIONS AS A SCREENING TEST FOR GENITAL CANCER.
    CAMERON CB; HUSAIN OA
    Br Med J; 1965 Jun; 1(5449):1529-30. PubMed ID: 14288104
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for cancer of the female genital tract in general medical and surgical wards.
    Wachtel E; Wycherley J; Lee CN
    Practitioner; 1972 Apr; 208(246):505-8. PubMed ID: 5031038
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-phosphogluconate dehydrogenase (6PGD) activity in the cervical mucus and vaginal fluid in benign and malignant gynaecological lesions.
    Brooks PC; Muir GG
    J Obstet Gynaecol Br Commonw; 1967 Feb; 74(1):111-4. PubMed ID: 6018084
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoma of the cervix. Automated methods for cancer screening.
    Husain OA; Cameron CB
    Proc R Soc Med; 1966 Oct; 59(10):982-6. PubMed ID: 5955773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaginal-cytological examination. Routine examination of a symptom-free young clientele].
    Hastrup J; Rojel K
    Ugeskr Laeger; 1968 Feb; 130(6):243-5. PubMed ID: 5676294
    [No Abstract]   [Full Text] [Related]  

  • 13. LABORATORY DIAGNOSIS OF EARLY MALIGNANT DISEASE. NEW DIAGNOSTIC TESTS FOR CANCER OF THE UTERUS.
    BONHAM DG
    Trans Med Soc Lond; 1964; 80():30-41. PubMed ID: 14270933
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine cervical screening of in-patients in a voluntary hospital.
    McDonald JR
    Acta Cytol; 1969 Aug; 13(8):455-8. PubMed ID: 5259258
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of pipette and smear methods in population screenings for carcinoma of the uterine cervix.
    Klinken L; Koch F; Albrechtsen R
    Dan Med Bull; 1972 Jun; 19(4):138-40. PubMed ID: 5041571
    [No Abstract]   [Full Text] [Related]  

  • 16. Mass cervical cancer screening program by irrigation smear in Japan.
    Kawashima Y; Ino S; Tashiro K; Tachibana M; Masukawa T
    Obstet Gynecol; 1968 Jul; 32(1):17-23. PubMed ID: 5742086
    [No Abstract]   [Full Text] [Related]  

  • 17. An island-wide screening program for cervical neoplasia in Barbados.
    Vaillant HW; Cummins GT; Richart RM
    Am J Obstet Gynecol; 1968 Aug; 101(7):943-6. PubMed ID: 5659952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence of adenocarcinoma of the uterine cervix in mass cytological and colposcopic diagnostic studies].
    Pieroni G; Cariaggi P; Ottaviano M; Marchionni M; Mincione G; Bartoloni St Omer F
    Minerva Ginecol; 1975 May; 27(5):418-21. PubMed ID: 1134695
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic test for cervical cancer.
    Goldberg DM; Watts C; Hart DM
    Br Med J; 1968 Feb; 1(5589):424-5. PubMed ID: 5639628
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistical methods in a screening program for cancer.
    Renwick DH
    Can J Public Health; 1969 Jul; 60(7):267-78. PubMed ID: 5804452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.